Processa Pharmaceuticals, Inc. — All Filings
625 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFR14A
DRS
DRSLTR
EFFECT
NT 10-K
NT 10-Q
PRE 14A
PRE 14C
PRER14A
RW
RW WD
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001567619-22-008363 | Apr 11, 2022 | Apr 1, 2022 |
| 4 | FORM 4 | 0001567619-22-008361 | Apr 11, 2022 | Apr 1, 2022 |
| 4 | FORM 4 | 0001567619-22-008312 | Apr 8, 2022 | Apr 6, 2022 |
| 4 | FORM 4 | 0001567619-22-008003 | Apr 4, 2022 | Nov 1, 2021 |
| 4 | FORM 4 | 0001567619-22-008012 | Apr 4, 2022 | Mar 31, 2022 |
| 4 | FORM 4 | 0001567619-22-008010 | Apr 4, 2022 | Mar 31, 2022 |
| 4 | FORM 4 | 0001567619-22-008008 | Apr 4, 2022 | Mar 31, 2022 |
| 4 | FORM 4 | 0001567619-22-008006 | Apr 4, 2022 | Mar 31, 2022 |
| 4 | FORM 4 | 0001567619-22-007998 | Apr 4, 2022 | Nov 1, 2021 |
| 4 | FORM 4 | 0001567619-22-007993 | Apr 4, 2022 | Nov 1, 2021 |
| 4 | FORM 4 | 0001567619-22-007987 | Apr 4, 2022 | Nov 1, 2021 |
| 4 | FORM 4 | 0001567619-22-007982 | Apr 4, 2022 | Nov 1, 2021 |
| 4 | FORM 4 | 0001567619-22-007980 | Apr 4, 2022 | Nov 1, 2021 |
| 10-K | — | 0001493152-22-008156 | Mar 30, 2022 | Dec 31, 2021 |
| 424B5 | — | 0001493152-22-007669 | Mar 24, 2022 | — |
| 8-K | — | 0001493152-22-007680 | Mar 24, 2022 | Mar 23, 2022 |
| 8-K | — | 0001493152-22-007101 | Mar 17, 2022 | — |
| 4 | FORM 4 | 0001567619-22-002079 | Jan 31, 2022 | Jan 27, 2022 |
| 8-K | — | 0001493152-22-002239 | Jan 26, 2022 | — |
| 4/A | FORM 4/A | 0001567619-22-000779 | Jan 6, 2022 | Dec 31, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000775 | Jan 6, 2022 | Dec 31, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000773 | Jan 6, 2022 | Dec 31, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000770 | Jan 6, 2022 | Dec 31, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000766 | Jan 6, 2022 | Dec 31, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000724 | Jan 6, 2022 | Sep 30, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000718 | Jan 6, 2022 | Sep 30, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000720 | Jan 6, 2022 | Sep 30, 2021 |
| 8-K | — | 0001493152-22-000543 | Jan 6, 2022 | Jan 1, 2022 |
| 4/A | FORM 4/A | 0001567619-22-000708 | Jan 6, 2022 | Sep 30, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000710 | Jan 6, 2022 | Sep 30, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000712 | Jan 6, 2022 | Sep 30, 2021 |
| 4/A | FORM 4/A | 0001567619-22-000782 | Jan 6, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-22-000291 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-22-000307 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-22-000304 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-22-000300 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-22-000296 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-22-000294 | Jan 4, 2022 | Dec 31, 2021 |
| 4 | FORM 4 | 0001567619-21-022195 | Dec 16, 2021 | Dec 14, 2021 |
| 4 | FORM 4 | 0001567619-21-021710 | Dec 7, 2021 | Dec 3, 2021 |
| 4 | FORM 4 | 0001567619-21-021708 | Dec 7, 2021 | Dec 3, 2021 |
| 10-Q | — | 0001493152-21-027929 | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | — | 0001493152-21-027320 | Nov 5, 2021 | Nov 3, 2021 |
| 4 | FORM 4 | 0001567619-21-018171 | Oct 8, 2021 | Oct 6, 2021 |
| 4 | FORM 4 | 0001567619-21-017825 | Oct 4, 2021 | Sep 30, 2021 |
| 4 | FORM 4 | 0001567619-21-017837 | Oct 4, 2021 | Sep 30, 2021 |
| 4 | FORM 4 | 0001567619-21-017833 | Oct 4, 2021 | Sep 30, 2021 |
| 4 | FORM 4 | 0001567619-21-017831 | Oct 4, 2021 | Sep 30, 2021 |
| 4 | FORM 4 | 0001567619-21-017829 | Oct 4, 2021 | Sep 30, 2021 |
| 4 | FORM 4 | 0001567619-21-017827 | Oct 4, 2021 | Sep 30, 2021 |